ENTITY

Canbas Co Ltd (4575 JP)

4
Analysis
Health CareJapan
CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects. The Company's core technologies include drugs that target the G2 checkpoint and a screening system to find selective abrogators of the G2 checkpoint.
more
bullishCanbas Co Ltd
12 Nov 2025 14:00Issuer-paid

Canbas Co Ltd (4575 JP): Q1 FY 06/26 flash update

CanBas reported no operating revenue in Q1 FY06/26, with an operating loss of JPY360mn and net loss of JPY349mn. R&D expenses increased by...

Logo
146 Views
Share
bullishCanbas Co Ltd
14 May 2025 08:00Issuer-paid

Canbas Co Ltd (4575 JP): Q3 FY06/25 flash update

Operating revenue was zero in cumulative Q3 FY06/24; operating loss was JPY799mn, and net loss JPY832mn. R&D expenses increased 70.8% YoY to...

Logo
185 Views
Share
bullishCanbas Co Ltd
14 Feb 2025 10:00Issuer-paid

Canbas Co Ltd (4575 JP): 1H FY06/25 flash update

CanBas reported no operating revenue and a net loss of JPY480mn, with R&D expenses increasing by 33.9% YoY. Total assets rose by JPY699mn due...

Logo
375 Views
Share
bullishCanbas Co Ltd
14 Nov 2024 17:00Issuer-paid

Canbas Co Ltd (4575 JP): Q1 FY06/25 flash update

CanBas reported no operating revenue in Q1 FY06/24, with an operating loss of JPY251mn and increased R&D expenses. Total assets rose by...

Logo
323 Views
Share
No more insights
x